These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 20696880

  • 1. Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.
    Parra-Ruiz J, Vidaillac C, Rose WE, Rybak MJ.
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4329-34. PubMed ID: 20696880
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
    Barber KE, Smith JR, Ireland CE, Boles BR, Rose WE, Rybak MJ.
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4497-503. PubMed ID: 25987623
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of High-Dose Daptomycin Versus Vancomycin Alone or Combined with Clarithromycin or Rifampin Against Staphylococcus aureus and S. epidermidis in a Novel In Vitro PK/PD Model of Bacterial Biofilm.
    Hall Snyder AD, Vidaillac C, Rose W, McRoberts JP, Rybak MJ.
    Infect Dis Ther; 2014 Dec 18; 4(1):51-65. PubMed ID: 25519162
    [Abstract] [Full Text] [Related]

  • 4. Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an In Vitro Biofilm Model.
    Jahanbakhsh S, Singh NB, Yim J, Kebriaei R, Smith JR, Lev K, Tran TT, Rose WE, Arias CA, Rybak MJ.
    Antimicrob Agents Chemother; 2020 Apr 21; 64(5):. PubMed ID: 32094136
    [Abstract] [Full Text] [Related]

  • 5. Activity of linezolid and high-dose daptomycin, alone or in combination, in an in vitro model of Staphylococcus aureus biofilm.
    Parra-Ruiz J, Bravo-Molina A, Peña-Monje A, Hernández-Quero J.
    J Antimicrob Chemother; 2012 Nov 21; 67(11):2682-5. PubMed ID: 22796888
    [Abstract] [Full Text] [Related]

  • 6. Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis.
    LaPlante KL, Woodmansee S.
    Antimicrob Agents Chemother; 2009 Sep 21; 53(9):3880-6. PubMed ID: 19564363
    [Abstract] [Full Text] [Related]

  • 7. Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms.
    Kunz Coyne AJ, Stamper K, Bleick C, Kebriaei R, Lehman SM, Rybak MJ.
    Microbiol Spectr; 2024 Apr 02; 12(4):e0321223. PubMed ID: 38411110
    [Abstract] [Full Text] [Related]

  • 8. Pharmacodynamics of moxifloxacin versus vancomycin against biofilms of methicillin-resistant Staphylococcus aureus and epidermidis in an in vitro model.
    Salem AH, Elkhatib WF, Ahmed GF, Noreddin AM.
    J Chemother; 2010 Aug 02; 22(4):238-42. PubMed ID: 20685626
    [Abstract] [Full Text] [Related]

  • 9. In-vitro activity of moxifloxacin combined with other antibacterials against methicillin-resistant Staphylococcus aureus.
    Maggiolo F, Capra R, Bottura P, Pravettoni G, Migliorino M, Suter F.
    J Chemother; 2000 Jun 02; 12(3):195-8. PubMed ID: 10877512
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of telavancin activity versus daptomycin and vancomycin against daptomycin-nonsusceptible Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
    Steed ME, Vidaillac C, Rybak MJ.
    Antimicrob Agents Chemother; 2012 Feb 02; 56(2):955-9. PubMed ID: 22123693
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of Telavancin Alone and Combined with Ceftaroline or Rifampin against Methicillin-Resistant Staphylococcus aureus in an In Vitro Biofilm Model.
    Jahanbakhsh S, Singh NB, Yim J, Rose WE, Rybak MJ.
    Antimicrob Agents Chemother; 2018 Aug 02; 62(8):. PubMed ID: 29784849
    [Abstract] [Full Text] [Related]

  • 12. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.
    Tsuji BT, Rybak MJ.
    Antimicrob Agents Chemother; 2005 Jul 02; 49(7):2735-45. PubMed ID: 15980344
    [Abstract] [Full Text] [Related]

  • 13. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
    Smith JR, Barber KE, Hallesy J, Raut A, Rybak MJ.
    Antimicrob Agents Chemother; 2015 Sep 02; 59(9):5529-34. PubMed ID: 26124162
    [Abstract] [Full Text] [Related]

  • 14. Bactericidal activity of ACH-702 against nondividing and biofilm Staphylococci.
    Podos SD, Thanassi JA, Leggio M, Pucci MJ.
    Antimicrob Agents Chemother; 2012 Jul 02; 56(7):3812-8. PubMed ID: 22547614
    [Abstract] [Full Text] [Related]

  • 15. Comparative efficacy of dalbavancin alone and with rifampicin against in vitro biofilms in a pharmacodynamic model with methicillin-resistant Staphylococcus aureus.
    El Haj C, Benavent E, Sierra Y, Soldevila L, Rigo-Bonnin R, Torrejón B, Gomez-Junyent J, Rosselló I, Murillo O.
    Int J Antimicrob Agents; 2022 Oct 02; 60(4):106664. PubMed ID: 36002115
    [Abstract] [Full Text] [Related]

  • 16. Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay using Galleria mellonella larvae.
    Luther MK, Arvanitis M, Mylonakis E, LaPlante KL.
    Antimicrob Agents Chemother; 2014 Aug 02; 58(8):4612-20. PubMed ID: 24867993
    [Abstract] [Full Text] [Related]

  • 17. The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance?
    El Haj C, Murillo O, Ribera A, Garcia-Somoza D, Tubau F, Cabellos C, Cabo J, Ariza J.
    Med Microbiol Immunol; 2017 Feb 02; 206(1):31-39. PubMed ID: 27639707
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.
    El Haj C, Murillo O, Ribera A, Lloberas N, Gómez-Junyent J, Tubau F, Fontova P, Cabellos C, Ariza J.
    Int J Antimicrob Agents; 2018 Jun 02; 51(6):854-861. PubMed ID: 29374577
    [Abstract] [Full Text] [Related]

  • 19. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
    Soriano A, Jurado A, Marco F, Almela M, Ortega M, Mensa J.
    Rev Esp Quimioter; 2005 Jun 02; 18(2):168-72. PubMed ID: 16130039
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
    Leonard SN, Rybak MJ.
    J Antimicrob Chemother; 2009 Jan 02; 63(1):155-60. PubMed ID: 18984644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.